The biomarkers identified in the T3 subtype include MSLN and CD117 (KIT), which have been reported in TC and other advanced tumor cells,[30, 31, 32] and CCL20 which has not been reported in TC (Figure 4i; Figure S12a, Supporting Information). The gene discussed is CCL20; the disease is neoplasm.